Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

著者: Jennifer R. Diamond, Carlos Becerra, Donald Richards, Alain C. Mita, Cynthia R. Osborne, Joyce O’Shaughnessy, Chun Zhang, Randall Henner, Ann M. Kapoun, Lu Xu, Bob Stagg, Shailaja Uttamsingh, Rainer K. Brachmann, Azeez Farooki, Monica Mita - Breast Cancer Research and Treatment 2020 被引用: 149